[HTML][HTML] Neoadjuvant chemotherapy for breast cancer: an evaluation of its efficacy and research progress
Y Chen, Y Qi, K Wang - Frontiers in Oncology, 2023 - frontiersin.org
Neoadjuvant chemotherapy (NAC) for breast cancer is widely used in the clinical setting to
improve the chance of surgery, breast conservation and quality of life for patients with …
improve the chance of surgery, breast conservation and quality of life for patients with …
Early prediction of pathologic complete response of breast cancer after neoadjuvant chemotherapy using longitudinal ultrafast dynamic contrast-enhanced MRI
Y Cao, X Wang, L Li, J Shi, X Zeng, Y Huang… - Diagnostic and …, 2023 - Elsevier
Purpose The purpose of this study was to evaluate the temporal trends of ultrafast dynamic
contrast-enhanced (DCE)-MRI during neoadjuvant chemotherapy (NAC) and to investigate …
contrast-enhanced (DCE)-MRI during neoadjuvant chemotherapy (NAC) and to investigate …
Accuracy of preoperative contrast-enhanced cone beam breast CT in assessment of residual tumor after neoadjuvant chemotherapy: a comparative study with breast …
Y Wang, M Zhao, Y Ma, A Liu, Y Zhu, L Yin, Z Liang… - Academic …, 2023 - Elsevier
Rationale and Objectives To compare the accuracy of preoperative contrast-enhanced cone
beam breast CT (CE-CBBCT) and MRI in assessment of residual tumor after neoadjuvant …
beam breast CT (CE-CBBCT) and MRI in assessment of residual tumor after neoadjuvant …
[HTML][HTML] Prediction of tumor progression during neoadjuvant chemotherapy and survival outcome in patients with triple-negative breast cancer
H Yoen, SY Kim, DW Lee, HB Lee… - Korean Journal of …, 2023 - ncbi.nlm.nih.gov
Objective To investigate the association of clinical, pathologic, and magnetic resonance
imaging (MRI) variables with progressive disease (PD) during neoadjuvant chemotherapy …
imaging (MRI) variables with progressive disease (PD) during neoadjuvant chemotherapy …
[HTML][HTML] Multiparametric MRI radiomics fusion for predicting the response and shrinkage pattern to neoadjuvant chemotherapy in breast cancer
Purpose During neoadjuvant chemotherapy (NACT), breast tumor morphological and
vascular characteristics are usually changed. This study aimed to evaluate the tumor …
vascular characteristics are usually changed. This study aimed to evaluate the tumor …
Changes in kinetic heterogeneity of breast cancer via computer-aided diagnosis on MRI predict the pathological response to neoadjuvant systemic therapy
L Hwangbo, JY Kim, JJ Kim, NK Lee, S Kim - European Radiology, 2023 - Springer
Objective To evaluate whether the computer-aided diagnosis (CAD)–extracted kinetic
heterogeneity of breast cancer on MRI and changes therein during treatment were …
heterogeneity of breast cancer on MRI and changes therein during treatment were …
Evaluation of multiparametric MRI radiomics-based nomogram in prediction of response to neoadjuvant chemotherapy in breast cancer: a two-center study
X Wang, H Hua, J Han, X Zhong, J Liu, J Chen - Clinical Breast Cancer, 2023 - Elsevier
Introduction This study evaluated the performance of primary foci of breast cancer on
multiparametric magnetic resonance imaging (MRI) contributing to establish and validate …
multiparametric magnetic resonance imaging (MRI) contributing to establish and validate …
[HTML][HTML] Early prediction of response to neoadjuvant chemotherapy using quantitative parameters on automated breast ultrasound combined with contrast-enhanced …
Y Xie, Y Chen, Q Wang, B Li, H Shang… - Ultrasound in Medicine & …, 2023 - Elsevier
Objective This prospective study was aimed at evaluating the role of automated breast
ultrasound (ABUS) and contrast-enhanced ultrasound (CEUS) in the early prediction of …
ultrasound (ABUS) and contrast-enhanced ultrasound (CEUS) in the early prediction of …
[HTML][HTML] Multiparametric magnetic resonance imaging in the assessment of pathological axillary lymph nodes in cases of breast cancer
RMA Hegazy, SMAR Khalil, SM Mokhtar… - Egyptian Journal of …, 2023 - Springer
Background Breast cancer is the most frequent cancer affecting females. It represents
leading cause of death from all cancers in females. Traditionally, axillary staging was …
leading cause of death from all cancers in females. Traditionally, axillary staging was …
RESEARCH PROGRESS ON PREPARATION AND ANTI-TUMOR APPLICATION OF COPPER SULFIDE NANOCOMPOSITES: A REVIEW.
Y Feng, H Miao, X Zeng… - Acta Poloniae …, 2023 - search.ebscohost.com
Photothermal diagnosis and treatment agents are more and more widely studied in cancer
diagnosis and treatment. Copper sulfide nanocomposite is an economical and superior …
diagnosis and treatment. Copper sulfide nanocomposite is an economical and superior …